Sarah Strot, DO
Vascular Surgery · Indianapolis, INNPI 1578944427
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Alphatec Spine, Inc at 30.4% of the total. Reporting peaked in 2023 at $6,388 and has fallen 86.2% since, to $879 in 2025.
Across 122 payments — averaging $119.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$4K
- W. L. Gore & Associates, Inc.$3K
- Medtronic$2K
- Silk Road Medical, Inc.$2K
- Endologix LLC$1K
- Cardiovascular Systems Inc.$523
- plus $1K from 14 others
What the payments were for
- Travel & lodging$7,24349%
- Food & beverage$6,79646%
- Education$5984%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 5 | $4,445 |
| W. L. Gore & Associates, Inc. | 39 | $3,141 |
| Medtronic(2 entities) | 18 | $2,147 |
| Silk Road Medical, Inc. | 9 | $1,819 |
| Endologix LLC | 19 | $1,232 |
| Cardiovascular Systems Inc. | 7 | $523 |
| Cook Medical LLC | 5 | $266 |
| Philips North America LLC | 2 | $146 |
| Penumbra, Inc. | 1 | $138 |
| Tactile Systems Technology Inc | 1 | $131 |
| Cvrx, Inc. | 1 | $130 |
| Terumo Medical Corporation | 3 | $110 |
| Johnson & Johnson(2 entities) | 2 | $108 |
| Smith+Nephew | 1 | $91 |
| Novartis | 3 | $64 |
| Stryker | 1 | $37 |
| KCI USA, Inc. | 2 | $36 |
| Lemaitre Vascular, Inc. | 1 | $35 |
| Edwards Lifesciences | 1 | $28 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other - Miscellaneous$4,132
- ENROUTE Transcarotid Neuroprotection System$2,054
- ENROUTE Transcarotid Stent$1,754
- PIVOX Oblique Lateral Spinal System$1,019
- EXCLUDER AAA Endoprosthesis$932
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$405
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$301
- Alto Abdominal Stent Graft System$283
- Diamondback Peripheral$254
- Ovation$243
- Endurant$223
- ENDURANT IIS$158
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$150
- Peripheral Orbital Atherectomy System$139
- Indigo System$138
- Conformable TAG Thoracic Endoprosthesis$137
- Vascular Graft$133
- Flexitouch Plus$131
- ENTRE$131
- Barostim Neo System$130
How this compares
$14,638 in reported general payments places this provider in the 80th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $11,807 |
| Cilostazol | 22 | $731 |
| ClopidogrelClopidogrel Bisulfate | 34 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $108 | $11,80718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Indianapolis
- Sajjad HussainIndianapolis$109K
- Andres FajardoIndianapolis$58K
- Brandon DowningIndianapolis$33K
- Deepak GuttikondaIndianapolis$33K
- Jeffrey WeinbergerIndianapolis$20K
- Randy IrwinIndianapolis$14K
- Mary ZornIndianapolis$12K
- Charles KiellIndianapolis$10K
- Hanaa Dakour AridiIndianapolis$8K
- Richard OfsteinIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.